Product Information
LAMIVUDINE 10 MG/ML ORAL SOLN is a generic product labeled by Chartwell RX LLC, priced at $0.2176 per ML under NDC 62135070637. Its NADAC has been published 110 times since May 22, 2024.
Strength
10 mg/mL
Manufacturer
Chartwell RX LLCNDC
62135070637
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LAMIVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA203564On Market Since
10/31/2014
Pharmacological Classes
Price Statistics
The NADAC for LAMIVUDINE 10 MG/ML ORAL SOLN has been published 110 times since May 22, 2024, and over the history we have for it it has declined 26.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2176 per ML |
|---|---|
| All-time high | $0.2955 (Jun 12, 2024) |
| All-time low | $0.2174 (Nov 20, 2024) |
| 52-week high | $0.2653 |
| 52-week low | $0.2176 |
| Median price | $0.2420 |
| Average price | $0.2451 |
| Largest weekly change | -14.7% (Nov 20, 2024) |
| Weeks tracked | 110 |
| Tracking since | May 22, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the lamivudine oral market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of LAMIVUDINE 10 MG/ML ORAL SOLN?
The current National Average Drug Acquisition Cost (NADAC) for LAMIVUDINE 10 MG/ML ORAL SOLN, manufactured by Chartwell RX LLC, is $0.2176 per ML (NDC 62135070637), effective Jun 24, 2026.
How has the price of LAMIVUDINE 10 MG/ML ORAL SOLN changed over time?
Over the history we have for it, the NADAC for LAMIVUDINE 10 MG/ML ORAL SOLN has declined 26.3%. It has been tracked across 110 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for LAMIVUDINE 10 MG/ML ORAL SOLN?
Since May 22, 2024, the NADAC for LAMIVUDINE 10 MG/ML ORAL SOLN has ranged from a low of $0.2174 (Nov 20, 2024) to a high of $0.2955 (Jun 12, 2024), with a median of $0.2420 per ML.
Are there cheaper alternatives to LAMIVUDINE 10 MG/ML ORAL SOLN?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of LAMIVUDINE 10 MG/ML ORAL SOLN, so no direct lower-cost alternative is listed.
Who manufactures LAMIVUDINE 10 MG/ML ORAL SOLN?
LAMIVUDINE 10 MG/ML ORAL SOLN (NDC 62135070637) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification